journal
Journals Clinical Gastroenterology and ...

Clinical Gastroenterology and Hepatology

https://read.qxmd.com/read/32707339/neoplasia-detection-rate-ndr-in-barrett-s-esophagus-and-its-impact-on-missed-dysplasia-results-from-a-large-population-based-database
#21
Lovekirat Dhaliwal, D Chamil Codipilly, Parth Gandhi, Michele L Johnson, Ramona Lansing, Kenneth K Wang, Cadman L Leggett, David A Katzka, Prasad G Iyer
BACKGROUND & AIMS: It is a challenge to detect dysplasia in Barrett's esophagus (BE) and esophageal adenocarcinomas (EACs) are missed in 25%-33% of cases. The neoplasia detection rate (NDR), defined as the rate of high-grade dysplasia (HGD) or EAC detection during initial surveillance endoscopy, has been proposed as a quality metric for endoscopic evaluation of patients with BE. However, current estimates are from referral center cohorts, which might overestimate NDR. Effects on rates of missed dysplasia are also unknown...
July 21, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32707338/factors-associated-with-adequate-lamina-propria-sampling-and-presence-of-lamina-propria-fibrosis-in-children-with-eosinophilic-esophagitis
#22
Girish Hiremath, Yash A Choksi, Sari Acra, Hernan Correa, Evan S Dellon
BACKGROUND & AIMS: Esophageal biopsies in children with eosinophilic esophagitis (EoE) are often inadequate for assessment of lamina propria and lamina propria fibrosis (LPF). For children with EoE, little is known about the factors associated with adequate lamina propria (aLP) sampling or the relationship among epithelial features in esophageal biopsies with and without LPF. We aimed to evaluate aLP in esophageal biopsies from children with and without EoE, identify factors associated with aLP and LPF, and examine the relationship among epithelial features in biopsies with and without LPF in children with EoE...
July 21, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32693048/screening-history-and-comorbidities-help-refine-stop-ages-for-colorectal-cancer-screening
#23
EDITORIAL
Audrey H Calderwood
Having rational data upon which to base recommendations for when reasonably to stop cancer screening is important from both an individual patient and public health perspective. Previous studies using the MISCAN-colon model have taken into account both age and co-morbidities without fulling accounting for variation in prior screening. In this issue of CGH, Cenin et al. demonstrate that prior screening history and comorbidities greatly influence appropriate stopping ages for colorectal cancer screening, with ages ranging from 66 to 90...
July 18, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32693047/factors-associated-with-delay-of-diagnosis-of-hepatocellular-carcinoma-in-patients-with-cirrhosis
#24
Debra T Choi, Jessica A Davila, Shubhada Sansgiry, Eric David, Hardeep Singh, Hashem B El-Serag, Yvonne Hsiao-Fan Sada
BACKGROUND & AIMS: We examined the frequency of and factors associated with delays in diagnosis of hepatocellular carcinoma (HCC) in a cohort of patients with cirrhosis in the Veterans Health Administration. METHODS: In a retrospective study, we collected and analyzed data from the Veterans Health Administration's electronic health records. We used a multivariate logistic regression model to identify factors associated with a delay in diagnosis of HCC of more than 60 days following a red flag (defined as the earliest date at which a diagnosis of HCC could have been made, based on American Association for the Study of Liver Disease 2005 guidelines)...
July 18, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32687977/risk-of-covert-submucosal-cancer-in-patients-with-granular-mixed-laterally-spreading-tumors
#25
F D'Amico, A Amato, A Iannone, C Trovato, C Romana, S Angeletti, R Maselli, F Radaelli, G Fiori, E Viale, E Di Giulio, P Soriani, M Manno, E Rondonotti, P A Galtieri, A Anderloni, A Fugazza, E Ferrara, S Carrara, M Di Leo, G Pellegatta, M Spadaccini, L Lamonaca, V Craviotto, P J Belletrutti, C Hassan, A Repici
BACKGROUND AND AIMS: Granular mixed laterally spreading tumors (GM-LSTs) have an intermediate level of risk for submucosal invasive cancer (SMICs) without clear signs of invasion (covert); the optimal resection method is uncertain. We aimed to determine the risk of covert SMIC in GM-LSTs based on clinical and endoscopic factors. METHODS: We collected data from 693 patients (50.6% male; median age, 69 years) with colorectal GM-LSTs, without signs of invasion, who underwent endoscopic resection (74...
July 17, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32683103/physical-activity-measured-objectively-is-associated-with-lower-mortality-in-patients-with-nonalcoholic-fatty-liver-disease
#26
Donghee Kim, Soumya Murag, George Cholankeril, Amanda Cheung, Stephen A Harrison, Zobair M Younossi, Aijaz Ahmed
BACKGROUNDS & AIMS: The association between physical activity (PA) and all-cause and cause-specific mortality from nonalcoholic fatty liver disease (NAFLD) requires investigation. We studied whether PA, measured by accelerometer, is associated with all-cause and cardiovascular mortality among individuals with NAFLD. METHODS: We performed a longitudinal analysis using the 2003-2006 US National Health and Nutrition Examination Survey data of adults (20 years or older) and collecting mortality data through December 2015...
July 16, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32683102/pseudomembranous-enteritis-presenting-protein-losing-enteropathy
#27
Eriko Takeshima, Akira Hokama, Jiro Fujita
No abstract text is available yet for this article.
July 16, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32683101/importance-of-disconnected-pancreatic-duct-syndrome-in-recurrence-of-pancreatic-fluid-collections-initially-drained-using-lumen-apposing-metal-stents
#28
Ji Young Bang, C Mel Wilcox, Juan Pablo Arnoletti, Shyam Varadarajulu
BACKGROUND & AIMS: Indwelling plastic endoprosthesis in patients with disconnected pancreatic duct syndrome (DPDS) reduces the risk of pancreatic fluid collection (PFC) recurrence. Although lumen-apposing metal stents (LAMS) are used with increasing frequency for PFC drainage, they require timely removal and little is known about their effects in patients with DPDS and recurrence of PFC. METHODS: We performed a prospective study of patients who underwent endoscopic ultrasound-guided drainage of PFC using LAMS and were found to have DPDS...
July 16, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32683100/the-clue-is-in-the-stool
#29
Slim Rita, El Gemayel Maria, Noun Roger
No abstract text is available yet for this article.
July 16, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32683099/endoscopic-radiologic-and-histologic-healing-with-vedolizumab-in-patients-with-active-crohn-s-disease
#30
Tarun Chhibba, Leonardo Guizzetti, Cynthia H Seow, Cathy Lu, Kerri L Novak, Ashwin N Ananthakrishnan, Charles N Bernstein, Gilaad G Kaplan, Remo Panaccione, Christopher Ma
BACKGROUND & AIMS: Vedolizumab is a gut-selective monoclonal antibody for treatment of moderately to severely active Crohn's disease (CD). We performed a prospective study of endoscopic, radiologic, and histologic healing in patients with CD who received vedolizumab therapy METHODS: We performed a phase 3b, open-label, single-group study of 101 patients with at least 3 months of active CD (a CD Activity Index score of 220-450, a simple endoscopic score for CD [SES-CD] of 7 or more, 1 or more mucosal ulcerations [identified by endoscopy], and failure of conventional therapy) from March 2015 through December 2017...
July 16, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32673642/pharmacology-clinical-effects-and-therapeutic-potential-of-cannabinoids-for-gastrointestinal-and-liver-diseases
#31
REVIEW
Daniel B Maselli, Michael Camilleri
Cannabis and cannabinoids (such as tetrahydrocannabinol and cannabidiol) are frequently used to relieve gastrointestinal symptoms. Cannabinoids have effects on the immune system and inflammatory responses, as well as neuromuscular and sensory functions of digestive organs, including pancreas and liver. Cannabinoids can cause hyperemesis and cyclic vomiting syndrome, but might also be used to reduce gastrointestinal, pancreatic, or hepatic inflammation, as well as to treat motility, pain, and functional disorders...
July 13, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32668344/gastric-emphysema-with-hepatic-portal-venous-gas-secondary-to-acute-gastric-mucosal-lesion
#32
Toshiyuki Morisawa, Mio Namikawa, Makoto Umeda
No abstract text is available yet for this article.
July 12, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32668343/per-oral-endoscopic-myotomy-biopsies-of-achalasia-patients-reveal-schwann-cell-depletion-in-the-muscularis-propria
#33
Chanakyaram A Reddy, Ryan Law, Henry D Appelman, Andrew C Chang, Sheryl Korsnes, Joan W Chen
No abstract text is available yet for this article.
July 12, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32668342/recycling-of-pre-colectomy-anti-tumor-necrosis-factor-agents-in-chronic-pouch-inflammation-is-associated-with-treatment-failure
#34
Maia Kayal, Thomas Lambin, Michael Plietz, Anam Rizvi, Marlana Radcliffe, Sergey Khaitov, Patricia Sylla, Alexander J Greenstein, Jean Frederic Colombel, Marla C Dubinsky, Ryan C Ungaro
No abstract text is available yet for this article.
July 12, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32668341/anxiety-and-depression-leads-to-anti-tumor-necrosis-factor-discontinuation-in-inflammatory-bowel-disease
#35
Casandra Dolovich, Charles N Bernstein, Harminder Singh, Zoann Nugent, Aruni Tennakoon, Leigh Ann Shafer, Ruth Ann Marrie, Jitender Sareen, Laura Targownik
BACKGROUND & AIMS: Anxiety and mood disorders (AMDs) are common among persons with inflammatory bowel diseases (IBD) and are associated with increased health care use and lower quality of life. We assessed the effects of AMDs on persistence on anti-tumor necrosis factor (anti-TNF) therapy in patients with IBD, and risk of IBD-related adverse outcomes after therapy initiation. METHODS: We identified all persons with IBD in Manitoba, Canada who were dispensed an anti-TNF agent from 2001 through 2016 and then identified those with a validated administrative definition of AMD in the 2 years before initiation of therapy...
July 12, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32668340/an-unusual-extrahepatic-hepatocellular-carcinoma
#36
Rachael Jacob, A Kasim Ismail, Emilia Prakoso
No abstract text is available yet for this article.
July 12, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32668339/monomorphic-epitheliotropic-intestinal-t-cell-lymphoma-a-rare-case-of-diffuse-ulcers-in-the-intestine
#37
Changqin Liu, Lijin Feng, Xiaomin Sun
No abstract text is available yet for this article.
July 12, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32668338/combination-therapy-does-not-improve-rate-of-clinical-or-endoscopic-remission-in-patients-with-inflammatory-bowel-diseases-treated-with-vedolizumab-or-ustekinumab
#38
Anne Hu, Paulo Gustavo Kotze, Alice Burgevin, Willam Tan, Alison Jess, Pei-Shun Li, Karen Kroeker, Brendan Halloran, Remo Panaccione, Laurent Peyrin-Biroulet, Christopher Ma, Ashwin N Ananthakrishnan
BACKGROUND & AIMS: Patients with Crohn's disease (CD) or ulcerative colitis (UC) often receive combination therapy with an immunomodulator and tumor necrosis factor antagonists, especially infliximab. However, the benefits of combination therapy with vedolizumab and ustekinumab are unclear. METHODS: We performed a retrospective study of patients with CD or UC initiating vedolizumab or ustekinumab therapy at Massachusetts General Hospital (USA), Alberta Health Sciences (Canada), or Nancy University Hospital (France) with at least 1 year of follow up...
July 12, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32663522/etiologies-and-features-of-acute-viral-hepatitis-in-spain
#39
J Llaneras, M Riveiro-Barciela, A Rando-Segura, C Marcos-Fosch, L Roade, F Velázquez, F Rodríguez-Frías, R Esteban, M Buti
BACKGROUND AND AIM: Etiologies of acute viral hepatitis in high-income countries change with migration of populations, lifestyle changes, and emergence of new pathogens. We analyzed etiologies, characteristics, and outcomes of patients with acute viral hepatitis at a tertiary hospital in Spain. METHODS: We analyzed data from all patients with acute hepatitis (n=100; 71% male; median age, 42 years; 72% Spanish nationals), older than 16 years, diagnosed in the emergency department of an academic hospital in Barcelona, Spain, from January 2014 through December 2018...
July 11, 2020: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/32663521/gastroenterologists-and-patients-report-high-satisfaction-rates-with-telehealth-services-during-the-novel-coronavirus-2019-covid-19-pandemic
#40
Avi Dobrusin, Fadi Hawa, Mark Gladshteyn, Paul Corsello, Kevin Harlen, Charlie Walsh, Latha Alaparthi, Michael Weinstein, Nadeem Baig, Andrew Sousa, Naresh T Gunaratnam
No abstract text is available yet for this article.
July 11, 2020: Clinical Gastroenterology and Hepatology
journal
journal
20073
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"